ACM Global Central Laboratory

New York, United States Founded: 1997 • Age: 29 yrs
Provides bioanalytical, central lab, and toxicology services for global clinical trials.
Annual revenue $468,612 Latest available
Total funding - Funding intelligence
Employees 10 Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors 11 Brand Intelligence

About ACM Global Central Laboratory

ACM Global Central Laboratory is a company based in New York (United States) founded in 1997. It operates as a B2B and Service-based. The company has 10 employees as of March 31, 2023. ACM Global Central Laboratory has completed 4 acquisitions, including ABS Laboratories, DRUGSCAN and DSI Medical Services. ACM Global Central Laboratory offers products and services including Large Molecule Bioanalysis, Clinical Trial Testing, Pharmacodynamic Biomarker Analysis, Toxicology Services, and Customized Sample Collection Kits. ACM Global Central Laboratory operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.

  • Headquarter New York, United States
  • Employees 10 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Acm Global Laboratories Private Limited
  • Date of Incorporation 08 Feb, 2011
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $468.61 K (USD)
    1.1
    as on Mar 31, 2023
  • Net Profit
    $10.77 K (USD)
    -26.84
    as on Mar 31, 2023
  • EBITDA
    $24.22 K (USD)
    -11.89
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    10

    as on Mar 31, 2023

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ACM Global Central Laboratory

ACM Global Central Laboratory offers a comprehensive portfolio of products and services, including Large Molecule Bioanalysis, Clinical Trial Testing, Pharmacodynamic Biomarker Analysis, Toxicology Services, and Customized Sample Collection Kits.

Product name locked
Category locked
Primary

Analysis of large molecules in biological samples for drug development.

Product name locked
Category locked
Locked

Testing for clinical trials including biomarker and safety analysis.

Product name locked
Category locked
Locked

Evaluation of biomarkers to assess drug effects in trials.

Product name locked
Category locked
Locked

Testing for drug levels and workplace substance analysis services.

Product name locked
Category locked
Locked

Kits for efficient sample collection in clinical research studies.

People of ACM Global Central Laboratory

Headcount 200-500
Employee Profiles 99
Employee Profiles
People
Ken Babineau
President
People
Susan Zalar
Scientific Affairs Analyst
People
Melanie Wiest
Quality Vendor Manager
People
Ashley Kimbrew
Business Development Specialist

Unlock access to complete

Funding Insights of ACM Global Central Laboratory

Premium access

Detailed funding history for ACM Global Central Laboratory

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ACM Global Central Laboratory

ACM Global Central Laboratory has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include ABS Laboratories, DRUGSCAN and DSI Medical Services.

Investments
Premium access

Investment portfolio details for ACM Global Central Laboratory

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Bio-analytical service provider for in-vitro, preclinical and clinical studies
Locked Locked 1995 Locked
Provider of drug and alcohol testing, background checks, and DOT physicals
Locked Locked 1991 Locked
Provider of toxicology and prescription drug monitoring services
Locked Locked 1985 Locked
Premium access

Complete acquisition details for ACM Global Central Laboratory

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - ACM Global Central Laboratory

Premium access

Detailed financials for ACM Global Central Laboratory

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Acm Global Central Laboratory Comparisons

ACM Global Central Laboratory Primary company
Description
Provides bioanalytical, central lab, and toxicology services...
Location
New York, United States
Founded Year
1997
Annual Revenue
$468.61 K (USD)
Net Profit
$10.77 K (USD)
EBITDA
$24.22 K (USD)
Employees
10
As of 2023
Premium access

Peer comparison for ACM Global Central Laboratory

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ACM Global Central Laboratory

ACM Global Central Laboratory operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Large-molecule bioanalysis is provided for biologics and biosimilars development.
Locked Locked Locked
Bioanalytical assays for drug development are developed and validated.
Locked Locked Locked
Analytical and quality assurance services are provided for diverse industries.
Locked Locked Locked
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
Locked Locked Locked
Integrated R&D services are provided for pharmaceuticals and allied sectors.
Locked Locked Locked
Microfluidics and mass spectrometry products are provided for clinical research.
Premium access

Detailed competitors of ACM Global Central Laboratory

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Acm Global Central Laboratory

Premium access

Complete news archive for ACM Global Central Laboratory

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ACM Global Central Laboratory

ACM Global Central Laboratory was founded in 1997.

ACM Global Central Laboratory is headquartered in New York, United States. It is registered at New York, New York, United States.

As of Mar 31, 2023, the latest employee count at ACM Global Central Laboratory is 10.

Annual revenue of ACM Global Central Laboratory is $468.61K as on Mar 31, 2023.

ACM Global Laboratories delivers central lab services, bioanalytical testing, and toxicology solutions to support clinical trials across more than 65 countries. They specialize in assay development, biomarker analysis, and specimen management, partnering with pharmaceutical clients to optimize drug development programs. Based in locations like Rochester, NY, and York, UK, they ensure customized testing and data-driven decisions for healthcare research.

ACM Global Central Laboratory's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.

ACM Global Central Laboratory offers Large Molecule Bioanalysis, Clinical Trial Testing, Pharmacodynamic Biomarker Analysis, Toxicology Services, and Customized Sample Collection Kits.

ACM Global Central Laboratory has made 4 acquisitions, including ABS Laboratories, DRUGSCAN, and DSI Medical Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available